A further 100 people received placebo. However, the primary endpoint looked at the change on the numeric pain rating scale (NPRS) from baseline, not compared to placebo. That allowed the trial to ...

Vertex Pharmaceuticals shares sank Thursday after the company reported mixed results in a Phase 2 drug trial to treat ...

The study met its primary endpoint with a statistically significant and clinically meaningful reduction in pain on the numeric pain rating scale (NPRS). The suzetrigine arm showed a statistically ...

Suzetrigine, an oral, highly selective NaV1.8 pain signal inhibitor, showed statistically significant and clinically meaningful reduction in pain on the numeric pain rating scale (NPRS ...

The study met its primary endpoint with statistically significant and clinically meaningful reduction in pain on the numeric pain rating scale, or NPRS. The suzetrigine arm showed a statistically ...

Placebo showed a reduction of -1.98 in the numeric pain rating scale or NPRS, while Suzetrigine recorded -2.02 on NPRS. The company said the results met primary endpoint with meaningful reduction ...